Stay updated on Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.6.3 instead of v3.6.2, indicating a small maintenance/version update to the page's metadata. This does not modify the substantive study content.
    Difference
    0.1%
    Check dated 2026-07-03T21:45:52.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays the site revision as v3.6.2, indicating a deployment update. This change does not modify the displayed study details.
    Difference
    0.1%
    Check dated 2026-06-26T19:34:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting was standardized and the revision label updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:03.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The revision label on the page changes from v3.5.4 to v3.5.5. This signals a new build/update of the page content and related assets.
    Difference
    0.1%
    Check dated 2026-06-05T08:29:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a minor backend or CMS update without changing the study details or visible content.
    Difference
    0.1%
    Check dated 2026-05-15T02:09:42.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new clinical study report synopsis item has been added to the Study Documents area, along with sponsor-related entries AbbVie and Helpful Links Provided by AbbVie.
    Difference
    0.2%
    Check dated 2026-05-07T21:47:57.000Z thumbnail image

Stay in the know with updates to Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Dose Regimens in Japanese GPP/EP Clinical Trial page.